Physician profile
Nancy Murphy
NPI 1912075086
$775.69
in general payments reported to CMS, 2019-2025
16 companies · $377 in 2025
The $377 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $121 · 2023: $59.61 · 2024: $218 · 2025: $377.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $655.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $654.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $121.08 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $104.55 | 2024 | Farxiga |
| Abiomed | $103.23 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $93.43 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $84.03 | 2025 | Jardiance |
| Xeris Pharmaceuticals, INC. | $46.74 | 2023-2025 | Gvoke Hypopen |
| Lilly USA, LLC | $35.48 | 2024-2025 | Mounjaro, Zepbound |
| Novo Nordisk INC | $30.72 | 2023-2024 | Ozempic, Rybelsus |
| Exact Sciences Corporation | $29.89 | 2025 | Cologuard Collection Kit |
| Insulet Corporation | $28.36 | 2025 | Omnipod |
| Shield Therapeutics INC | $18.92 | 2024 | |
| Phathom Pharmaceuticals, INC. | $17.68 | 2025 | Voquezna |
| Alkermes, INC. | $16.60 | 2025 | Vivitrol |
| Novartis Pharmaceuticals Corporation | $15.81 | 2025 | |
| Abbvie INC. | $15.24 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $13.93 | 2023 | Octaray Mapping Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.